HAYWARD, Calif .– (BUSINESS WIRE) – Malawi DNA Technologies’ iSWAB-Microbiome-EL sample collection technology enables BioTech Africa to implement and launch a new very high throughput COVID-19 testing program. This breakthrough, in conjunction with 3CR Bioscience’s ProbeSure ™ COVID-19 One Step RT-PCR Kit, is designed to achieve a capacity of 200,000 tests per day.
“We are extremely proud and honored to be a part of South Africa’s fight against COVID-19 through BioTech Africa’s mass testing efforts,” said Dr Bassam El-Fahmawi, President and Chief Technical Officer of Mawi DNA Technologies.
In addition, Dr. Jenny Leslie, COO of BioTech Africa, worked closely with Scilutions Labware and Hook Diagnostics to identify the best products and partner vendors who could provide reagents to streamline the testing workflow, but also s’ adapt to projected numbers with minimal supply chain disruption.
“For the sample collection step, the iSWAB-Microbiome-EL (‘Extractionless’) product from Mawi DNA Technologies was chosen for its multiple advantages. This includes activating direct PCR by suppressing the RNA extraction step with prolonged room temperature stabilization of the viral RNA. The iSWAB technology also enables simple and efficient non-invasive self-collection, a key part of BioTech Africa’s testing strategy to encourage widespread compliance, ”said Dr Leslie. She added, “When used in tandem with the 3CR Bioscience ProbeSure ™ Kit, we can provide high throughput assays and faster sample-to-result processing time, while dramatically reducing reagents, plastics and waste. footprint of the workflow.
“ISWAB room temperature sample collection and stabilization technology has been well validated in the field with millions of samples tested to date,” said Dr Bassam El-Fahmawi. He added that Mawi DNA was pleased to work with Scilutions Labware and Hook Diagnostics to deploy their products globally to help mitigate the socio-economic impact of COVID-19 on the world.
Hook Diagnostics CEO Simon Kratzat added, “Our mission at Hook Diagnostics is to enable affordable testing at the population level. We are honored to make this a reality for BioTech Africa with Mawi DNA, 3CR and Scilutions. ”
About Mawi DNA Technologies
Mawi DNA Technologies has developed and marketed iSWAB technology, an innovative system for collecting biological samples. Its flagship product, iSWAB-DNA, has gained strong popularity in the market due to its ability to be used for animals and all segments of the human population, from infants to the elderly, with robust DNA yield and low content of bacterial DNA. iSWAB-Microbiome has gained worldwide acceptance as a superior collection technology for COVID-19 samples. Mawi DNA has expanded its offering to include technologies for the collection of intact cells and whole blood. For more information visit http://www.mawidna.com.
About BioTech Africa
BioTech Africa specializes in the production and bioprocessing of recombinant proteins. Driven by the global demand for improved in vitro diagnostics, its current line of highly purified recombinant proteins are used in the manufacture of diagnostic test kits for rapid diagnostic and point-of-care research institutes. BioTech Africa offers a variety of protein expression platforms as well as a host of other protein services, including protein folding and structural biology analysis. For more information visit http://www.biotechafrica.com.
About the Scilutions lab software
Scilutions is an innovative manufacturer of scientific products. Through collaboration with academia, industry and …
- According to the source Sample collection without Mawi DNA extraction Technology Enables BioTech Africa to Launch Affordable COVID-19 Mass Testing Platform
- Check all news and articles from the tech news updates.
For Latest Updates Follow us on Google News
- Show all
- Most Viewed